Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme-Reference-Cited by-同舟云学术

Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme

Published:2013-07-13 Issue:9 Volume:97 Page:1161-1167
ISSN:0007-1161
Container-title:British Journal of Ophthalmology
language:en
Short-container-title:Br J Ophthalmol

Author:

Holz Frank G,Bandello Francesco,Gillies Mark,Mitchell Paul,Osborne Aaron,Sheidow Tom,Souied Eric,Figueroa Marta S,

Publisher

BMJ

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference29 articles.

1. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

2. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study;Brown;Ophthalmology,2009

3. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

4. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study;Brown;Ophthalmology,2011

5. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study;Campochiaro;Ophthalmology,2011

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does ranibizumab biosimilars fare as well in macular neovascularisation?;Indian Journal of Clinical and Experimental Ophthalmology;2024-03-15

2. Results of anti-VEGF treatment for neovascular AMD in eyes with different baseline visual acuity in Turkish population-based on real life data-Bosphorus retina study group;Photodiagnosis and Photodynamic Therapy;2023-06

3. oregis—The German ophthalmological registry;Die Ophthalmologie;2023-01-12

4. A Real-World, Multicenter, 6-Month Prospective Study in Greece of the Effectiveness and Safety of Ranibizumab in Patients with Age-Related Macular Degeneration Who Have Inadequately Responded to Aflibercept: The “ELEVATE” Study;Clinical Ophthalmology;2022-08

5. Intravitreal Aflibercept Therapy and Treatment Outcomes of Eyes with Neovascular Age-Related Macular Degeneration in a Real-Life Setting: A Five-Year Follow-Up Investigation;Ophthalmology and Therapy;2022-01-19